As both a journalist and analyst, Mike has been writing, analyzing and commenting on the life sciences industry for more than 35 years. His actionable insights and analysis support pharma, biotech, healthcare and medtech stakeholders gain a deeper understanding of market news and trends. Mike has held editorial and content leadership roles at various publications and organizations across the industry.
These seven late-stage experimental treatments stand to advance human health in 2022.
Let's stay in touch. Subscribe to our latest announcements.